Loading clinical trials...
Loading clinical trials...
Radiation Therapy With or Without Curcumin Supplement in Treating Patients With Prostate Cancer
Prostate cancer is the second most incident cancer among male population worldwide. Radiation therapy by itself or along with surgery and chemotherapy are the main treatments for prostate cancer however prostate cancer cells are only modestly responsive or even unresponsive to the cytotoxic effects of radiotherapy. Recently some in vitro and in vivo studies showed radiosensitizing and radioprotective effects for curcumin. No clinical trial has been done in this area and it is not yet known whether radiation therapy is more effective with or without curcumin supplements in treating patients with prostate cancer.
Age
50 - 80 years
Sex
MALE
Healthy Volunteers
No
Oncology and radiotherapy department, Besat Hospital
Tehran, Tehran Province, Iran
Start Date
March 1, 2011
Primary Completion Date
October 1, 2013
Completion Date
October 1, 2013
Last Updated
November 18, 2015
40
ACTUAL participants
Curcumin
DIETARY_SUPPLEMENT
Placebo
DIETARY_SUPPLEMENT
Lead Sponsor
Shahid Beheshti University of Medical Sciences
NCT05691465
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions